
OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Molecular aspects of Omicron, vaccine development, and recombinant strain XE: A review
K. Akash, Avinash Sharma, Deepak Kumar, et al.
Journal of Medical Virology (2022) Vol. 94, Iss. 10, pp. 4628-4643
Open Access | Times Cited: 22
K. Akash, Avinash Sharma, Deepak Kumar, et al.
Journal of Medical Virology (2022) Vol. 94, Iss. 10, pp. 4628-4643
Open Access | Times Cited: 22
Showing 22 citing articles:
Evolution of SARS-CoV-2 Variants: Implications on Immune Escape, Vaccination, Therapeutic and Diagnostic Strategies
Nur Zawanah Zabidi, Hern Liang Liew, Isra Ahmad Farouk, et al.
Viruses (2023) Vol. 15, Iss. 4, pp. 944-944
Open Access | Times Cited: 70
Nur Zawanah Zabidi, Hern Liang Liew, Isra Ahmad Farouk, et al.
Viruses (2023) Vol. 15, Iss. 4, pp. 944-944
Open Access | Times Cited: 70
Targetable elements in SARS-CoV-2 S2 subunit for the design of pan-coronavirus fusion inhibitors and vaccines
Liyan Guo, Sheng Lin, Zimin Chen, et al.
Signal Transduction and Targeted Therapy (2023) Vol. 8, Iss. 1
Open Access | Times Cited: 48
Liyan Guo, Sheng Lin, Zimin Chen, et al.
Signal Transduction and Targeted Therapy (2023) Vol. 8, Iss. 1
Open Access | Times Cited: 48
Molecular evolution of SARS‐CoV‐2 from December 2019 to August 2022
Jonas Michel Wolf, Lucas Wolf, Graziele Lima Bello, et al.
Journal of Medical Virology (2022) Vol. 95, Iss. 1
Open Access | Times Cited: 57
Jonas Michel Wolf, Lucas Wolf, Graziele Lima Bello, et al.
Journal of Medical Virology (2022) Vol. 95, Iss. 1
Open Access | Times Cited: 57
Carrimycin inhibits coronavirus replication by decreasing the efficiency of programmed –1 ribosomal frameshifting through directly binding to the RNA pseudoknot of viral frameshift-stimulatory element
Hongying Li, Jianrui Li, Jiayu Li, et al.
Acta Pharmaceutica Sinica B (2024) Vol. 14, Iss. 6, pp. 2567-2580
Open Access | Times Cited: 6
Hongying Li, Jianrui Li, Jiayu Li, et al.
Acta Pharmaceutica Sinica B (2024) Vol. 14, Iss. 6, pp. 2567-2580
Open Access | Times Cited: 6
Development of variant‐proof severe acute respiratory syndrome coronavirus 2, pan‐sarbecovirus, and pan‐β‐coronavirus vaccines
Jie Zhou, Zezhong Liu, Guangxu Zhang, et al.
Journal of Medical Virology (2022) Vol. 95, Iss. 1
Open Access | Times Cited: 22
Jie Zhou, Zezhong Liu, Guangxu Zhang, et al.
Journal of Medical Virology (2022) Vol. 95, Iss. 1
Open Access | Times Cited: 22
Identification of key mutations responsible for the enhancement of receptor-binding affinity and immune escape of SARS-CoV-2 Omicron variant
Wei Bu Wang, Bo Yi, Ze Hua Lei, et al.
Journal of Molecular Graphics and Modelling (2023) Vol. 124, pp. 108540-108540
Open Access | Times Cited: 11
Wei Bu Wang, Bo Yi, Ze Hua Lei, et al.
Journal of Molecular Graphics and Modelling (2023) Vol. 124, pp. 108540-108540
Open Access | Times Cited: 11
Enhancing Public Health Outcomes with AI-Powered Clinical Surveillance: Precise Detection of COVID-19 Variants using qPCR and Nanopore Sequencing
Hsing‐Yi Chung, Ming‐Jr Jian, Chih-Kai Chang, et al.
Journal of Infection and Public Health (2025) Vol. 18, Iss. 3, pp. 102663-102663
Open Access
Hsing‐Yi Chung, Ming‐Jr Jian, Chih-Kai Chang, et al.
Journal of Infection and Public Health (2025) Vol. 18, Iss. 3, pp. 102663-102663
Open Access
Microalgae as an Efficient Vehicle for the Production and Targeted Delivery of Therapeutic Glycoproteins against SARS-CoV-2 Variants
Jaber Dehghani, Ali Movafeghi, Elodie Mathieu‐Rivet, et al.
Marine Drugs (2022) Vol. 20, Iss. 11, pp. 657-657
Open Access | Times Cited: 18
Jaber Dehghani, Ali Movafeghi, Elodie Mathieu‐Rivet, et al.
Marine Drugs (2022) Vol. 20, Iss. 11, pp. 657-657
Open Access | Times Cited: 18
Investigation of the N-Glycosylation of the SARS-CoV-2 S Protein Contained in VLPs Produced in Nicotiana benthamiana
Juliette Balieu, Jae-Wan Jung, Philippe Chan, et al.
Molecules (2022) Vol. 27, Iss. 16, pp. 5119-5119
Open Access | Times Cited: 17
Juliette Balieu, Jae-Wan Jung, Philippe Chan, et al.
Molecules (2022) Vol. 27, Iss. 16, pp. 5119-5119
Open Access | Times Cited: 17
The salivary and nasopharyngeal microbiomes are associated with SARS‐CoV‐2 infection and disease severity
Josh G. Kim, Ai Zhang, Adriana M. Rauseo, et al.
Journal of Medical Virology (2022) Vol. 95, Iss. 2
Open Access | Times Cited: 14
Josh G. Kim, Ai Zhang, Adriana M. Rauseo, et al.
Journal of Medical Virology (2022) Vol. 95, Iss. 2
Open Access | Times Cited: 14
The nuts and bolts of recombination in the generation of SARS-CoV-2 variants; from XA to XBB
Bardia Karim, Mohammad Barary, Zahra Fereydouni, et al.
Letters in Applied Microbiology (2024) Vol. 77, Iss. 8
Open Access | Times Cited: 2
Bardia Karim, Mohammad Barary, Zahra Fereydouni, et al.
Letters in Applied Microbiology (2024) Vol. 77, Iss. 8
Open Access | Times Cited: 2
Antibody Response Following the Intranasal Administration of SARS-CoV-2 Spike Protein-CpG Oligonucleotide Vaccine
Kentaro Muranishi, Mao Kinoshita, Keita Inoue, et al.
Vaccines (2023) Vol. 12, Iss. 1, pp. 5-5
Open Access | Times Cited: 4
Kentaro Muranishi, Mao Kinoshita, Keita Inoue, et al.
Vaccines (2023) Vol. 12, Iss. 1, pp. 5-5
Open Access | Times Cited: 4
Investigating the Antibody Imprinting Hypothesis among Canadian Paramedics after SARS-CoV-2 Omicron Variant Circulation
Michael Asamoah-Boaheng, Brian Grunau, Mohammad Ehsanul Karim, et al.
ImmunoHorizons (2024) Vol. 8, Iss. 2, pp. 193-197
Open Access | Times Cited: 1
Michael Asamoah-Boaheng, Brian Grunau, Mohammad Ehsanul Karim, et al.
ImmunoHorizons (2024) Vol. 8, Iss. 2, pp. 193-197
Open Access | Times Cited: 1
From oncogenes to tumor suppressors: The dual role of ncRNAs in fibrosarcoma
Imran Kazmi, Muhammad Afzal, Waleed Hassan Almalki, et al.
Pathology - Research and Practice (2024) Vol. 258, pp. 155329-155329
Closed Access | Times Cited: 1
Imran Kazmi, Muhammad Afzal, Waleed Hassan Almalki, et al.
Pathology - Research and Practice (2024) Vol. 258, pp. 155329-155329
Closed Access | Times Cited: 1
Raman Fingerprints of SARS-CoV-2 Omicron Subvariants: Molecular Roots of Virological Characteristics and Evolutionary Directions
Giuseppe Pezzotti, Eriko Ohgitani, Yuki Fujita, et al.
ACS Infectious Diseases (2023) Vol. 9, Iss. 11, pp. 2226-2251
Open Access | Times Cited: 2
Giuseppe Pezzotti, Eriko Ohgitani, Yuki Fujita, et al.
ACS Infectious Diseases (2023) Vol. 9, Iss. 11, pp. 2226-2251
Open Access | Times Cited: 2
Recent progress on drugs discovery study for treatment of COVID-19: repurposing existing drugs and current natural bioactive molecules
Ika Oktavianawati, Mardi Santoso, Mohd Fadzelly Abu Bakar, et al.
Applied Biological Chemistry (2023) Vol. 66, Iss. 1
Open Access | Times Cited: 2
Ika Oktavianawati, Mardi Santoso, Mohd Fadzelly Abu Bakar, et al.
Applied Biological Chemistry (2023) Vol. 66, Iss. 1
Open Access | Times Cited: 2
Molecular, Immunological, and Clinical Characterization of SARS-CoV-2 Infection in Breakthrough-Infected Healthcare Workers During the Last Wave of The Pandemic in Shiraz, Iran
Sepideh Saeb, Gholam Reza Talei, Azam Ghaziasadi, et al.
Jundishapur Journal of Microbiology (2024) Vol. 16, Iss. 11
Open Access
Sepideh Saeb, Gholam Reza Talei, Azam Ghaziasadi, et al.
Jundishapur Journal of Microbiology (2024) Vol. 16, Iss. 11
Open Access
Prospects of Innovative Therapeutics in Combating the COVID-19 Pandemic
Thamby Rajah Mahendran, Binsin Cynthia, Ramesh Thevendran, et al.
Molecular Biotechnology (2024)
Closed Access
Thamby Rajah Mahendran, Binsin Cynthia, Ramesh Thevendran, et al.
Molecular Biotechnology (2024)
Closed Access
An ARMS-Multiplex PCR Targeting SARS-CoV-2 Omicron Sub-Variants
Petros Bozidis, Eleni Petridi, Konstantina Gartzonika
Pathogens (2023) Vol. 12, Iss. 8, pp. 1017-1017
Open Access | Times Cited: 1
Petros Bozidis, Eleni Petridi, Konstantina Gartzonika
Pathogens (2023) Vol. 12, Iss. 8, pp. 1017-1017
Open Access | Times Cited: 1
Surfing the Waves of SARS-CoV-2: Analysis of Viral Genome Variants Using an NGS Survey in Verona, Italy
Emil Tonon, Riccardo Cecchetto, Erica Diani, et al.
Microorganisms (2024) Vol. 12, Iss. 5, pp. 846-846
Open Access
Emil Tonon, Riccardo Cecchetto, Erica Diani, et al.
Microorganisms (2024) Vol. 12, Iss. 5, pp. 846-846
Open Access
Molecular Characterization of Whole-Genome SARS-CoV-2 from the First Suspected Cases of the XE Variant in the Lazio Region, Italy
Martina Rueca, Emanuela Giombini, Giulia Gramigna, et al.
Diagnostics (2022) Vol. 12, Iss. 9, pp. 2219-2219
Open Access
Martina Rueca, Emanuela Giombini, Giulia Gramigna, et al.
Diagnostics (2022) Vol. 12, Iss. 9, pp. 2219-2219
Open Access